Ansbert Gadicke - 17 May 2022 Form 4 Insider Report for Allovir, Inc. (ALVR)

Role
Director, 10%+ Owner
Signature
/s/ Brett Hagen, as Attorney-in-Fact
Issuer symbol
ALVR
Transactions as of
17 May 2022
Transactions value $
$0
Form type
4
Filing time
19 May 2022, 16:27:20 UTC
Previous filing
06 Jan 2022
Next filing
23 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALVR Stock Option (Right to Buy) Award $0 +27.5K $0.00 27.5K 17 May 2022 Common Stock 27.5K $4.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable upon the earlier to occur of (i) May 17, 2023 and (ii) the next annual meeting of the Issuer's stockholders.